NCT01100931 2015-10-19A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)National Institutes of Health Clinical Center (CC)Phase 1/2 Completed42 enrolled 12 charts